Successful or Uncomplicated Use of Drug‐Coated Balloon Versus Drug‐Eluting Stent Strategies for De Novo Culprit Lesions in Acute Coronary Syndromes: Insights from a Nationwide Registry in Japan

医学 急性冠脉综合征 危险系数 经皮冠状动脉介入治疗 内科学 心肌梗塞 罪魁祸首 蒂米 冲程(发动机) 支架 入射(几何) 药物洗脱支架 心脏病学 外科 置信区间 工程类 物理 光学 机械工程
作者
T Takahashi,Kyohei Yamaji,Shun Kohsaka,Hideki Ishii,Yuichiro Mori,Yuetsu Kikuta,Tetsuzo Wakatsuki,Koji Yamaguchi,Daisuke Nishioka,Kenya Kusunose,Tetsuya Amano,Masataka Sata,Ken Kozuma,Shiro Uemura,Yutaka Hikichi,Osamu Iida,Yuji Ikari,Koichi Kaikita,Yoshio Kobayashi,Toshiro Shinke
出处
期刊:Journal of the American Heart Association [Wiley]
被引量:1
标识
DOI:10.1161/jaha.124.038071
摘要

Background Randomized trials demonstrated that drug‐coated balloon (DCB) was not inferior to drug‐eluting stent (DES) for acute coronary syndrome (ACS). However, generalizability in clinical settings remains unclear. The present study compared the outcomes of DCB and DES strategies in percutaneous coronary intervention for ACS within a nationwide procedure‐based registry. Methods and Results This was a retrospective analysis of a cohort study from a prospective, nationwide registry between January 2017 and December 2020 in Japan, focusing on patients with ACS who underwent DCB or DES for a single de novo lesion. Patients who required bailout stenting after treatment with DCB were excluded from the analysis. The 1‐year incidence of all‐cause mortality, cardiovascular death, noncardiovascular death, nonfatal ACS, stroke, and major bleeding events was compared. A subgroup analysis included lesion‐based and ST‐elevation myocardial infarction/non‐ST‐elevation ACS stratifications. Among 5212 propensity score–matched patients with ACS, no significant differences were observed in the 1‐year incidence of all‐cause mortality (4.5% versus 4.6%, hazard ratio [HR], 0.92 [95% CI, 0.72–1.19]); cardiovascular death (2.5% versus 2.5%, HR, 0.90 [95% CI, 0.64–1.26]); noncardiovascular death (2.0% versus 2.1%, HR, 0.96 [95% CI, 0.65–1.42]); or nonfatal ACS (1.7% versus 2.0%, HR, 1.04 [95% CI, 0.70–1.54]) between DCB and DES. DCB was associated with a higher incidence of stroke (0.8% versus 0.3%, HR, 2.33 [95% CI, 1.06–5.08]) and lower incidence of major bleeding events (1.4% versus 2.3%, HR, 0.65 [95% CI, 0.43–0.99]); however, these results were not reproduced in the subgroup analysis. Conclusions The DCB strategy for successfully treated ACS cases achieved similar clinical outcomes to DES after 1 year. Further studies with an extended follow‐up are needed to confirm these results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
米奇奇奇完成签到,获得积分10
刚刚
刚刚
wanci应助啾啾采纳,获得10
2秒前
2秒前
睡醒精神好完成签到 ,获得积分10
2秒前
2秒前
3秒前
FashionBoy应助啵啵采纳,获得10
3秒前
4秒前
5秒前
qq完成签到 ,获得积分10
5秒前
angewbaby完成签到,获得积分10
5秒前
七月流火重新开启了kou文献应助
6秒前
YANG_Shuo发布了新的文献求助10
6秒前
7秒前
丘比特应助张憨憨采纳,获得10
7秒前
7秒前
陶俊祺完成签到,获得积分10
9秒前
叶揽风声完成签到,获得积分10
9秒前
Lchno1完成签到 ,获得积分10
11秒前
田様应助HP采纳,获得10
11秒前
11秒前
linyink发布了新的文献求助10
11秒前
NexusExplorer应助叶揽风声采纳,获得10
11秒前
Owen应助夏梓硕采纳,获得10
11秒前
12秒前
所所应助PhD_Lee73采纳,获得10
12秒前
宇心发布了新的文献求助30
12秒前
zkL完成签到,获得积分10
12秒前
LI发布了新的文献求助10
12秒前
12秒前
12秒前
myg8627完成签到,获得积分10
13秒前
13秒前
英吉利25发布了新的文献求助10
14秒前
zzn完成签到,获得积分10
14秒前
czx完成签到,获得积分10
14秒前
15秒前
LHR发布了新的文献求助10
16秒前
皮皮皮卡球完成签到,获得积分20
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7771049
求助须知:如何正确求助?哪些是违规求助? 9313830
关于积分的说明 20335640
捐赠科研通 7356303
什么是DOI,文献DOI怎么找? 3316608
关于科研通互助平台的介绍 2465220
邀请新用户注册赠送积分活动 2331516